EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction‐Associated Steatotic Liver Disease

Kaori Inoue, Kaoru Araki, Kaoru Shibayama, Tomomi Yada, Nagisa Hara, Satoshi Oeda iD, Kazuma Udo, Shohei Tobu iD, Shun Yamashita, Hiroshi Isoda, Yuichiro Eguchi iD, Keizo Anzai und 2 weitere

JGH Open · 2026-06 · 10 (6)

DOI: 10.1002/jgh3.70436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JGH Open, online erschienen am 20.06.2026. Verfasst von Kaori Inoue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Liver Center, Saga University Hospital Saga Japan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Metabolic dysfunction‐associated steatotic liver disease (MASLD), causing cirrhosis and liver cancer, is prevalent worldwide. Analyses of internet searches for “fatty liver” and methods to raise MASLD awareness are needed.

Methods

We retrospectively analyzed co‐occurring terms with “fatty liver” and tracked search histories to identify key terms. In a comparative study, a banner advertisement about MASLD was shown to individuals searching for key terms (key term group: KTG) or regardless of the search terms (control group: CTR). The ad redirected viewers to an educational cartoon, followed by a questionnaire.

Results

The most frequent co‐occurrence term was “how to treat.” People searched mainly for lifestyle‐related disease and diet terms. Key terms included “diet,” “blood sugar level,” “cholesterol,” “triglyceride,” “visceral fat,” and “antihypertensive drugs.” Banner views were 5 864 184 for KTG and 49 388 176 for CTR. KTG had a higher click‐through rate than CTR (0.097% vs. 0.063%; p < 0.001) and more survey responses (3.22% vs. 0.84%; p < 0.001). KTG participants also had a greater intention to seek medical care early (60.2% vs. 42.4%; p = 0.003).

Conclusion

Search term‐based advertising may help increase public awareness of MASLD and may encourage earlier intention to seek medical consultation.

Schlagwörter

Stichwörter der Autor:innen

banner advertisementclick‐through rateco‐occurrence termmetabolic dysfunction‐associated steatotic liver diseasesearch history

Autor:innen und Institutionen

  • Liver Center, Saga University Hospital Saga Japan.
  • Education and Research Center for Community Medicine, Faculty of Medicine Saga University Saga Japan.
  • Office for Equality, Diversity, and Inclusion, Saga University Saga Japan.
  • Health Care Center, Saga University Saga Japan.
  • Institute of Nursing, Faculty of Medicine Saga University Saga Japan.
  • Loco Medical General Institute Saga Japan.

ORCID-Profile: Satoshi Oeda, Shohei Tobu, Yuichiro Eguchi, Hirokazu Takahashi

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Inoue, K., Araki, K., Shibayama, K., Yada, T., Hara, N., Oeda, S., Udo, K., Tobu, S., Yamashita, S., Isoda, H., Eguchi, Y., Anzai, K., Noguchi, M., & Takahashi, H. (2026). Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction‐Associated Steatotic Liver Disease. JGH Open, 10(6). https://doi.org/10.1002/jgh3.70436

Vancouver

Inoue K, Araki K, Shibayama K, Yada T, Hara N, Oeda S, et al. Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction‐Associated Steatotic Liver Disease. JGH Open. 2026;10(6). doi:10.1002/jgh3.70436

BibTeX
@article{Inoue2026,
  author = {Inoue, Kaori and Araki, Kaoru and Shibayama, Kaoru and Yada, Tomomi and Hara, Nagisa and Oeda, Satoshi and Udo, Kazuma and Tobu, Shohei and Yamashita, Shun and Isoda, Hiroshi and Eguchi, Yuichiro and Anzai, Keizo and Noguchi, Mitsuru and Takahashi, Hirokazu},
  title = {Novel Internet Advertising Approach to Raise Public Awareness About Metabolic Dysfunction‐Associated Steatotic Liver Disease},
  journal = {JGH Open},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1002/jgh3.70436}
}
Kostenlos starten →